Home/Lamassu Biotech/Greg Palmer, Ph.D.
GP

Greg Palmer, Ph.D.

Chief Scientific Officer & Co-Founder

Lamassu Biotech

Lamassu Biotech Pipeline

DrugIndicationPhase
SA53p53 wild-type tumors (Oncology)Phase 1/2
RABI-767Acute PancreatitisPhase 2